KT&G's Approach to Vapor Products in Korea

Dec.30.2022
KT&G's Approach to Vapor Products in Korea
KT&G focuses on HNB products, combining vaporization and heating technology, and has not developed a separate vape brand due to government regulations.

Why has KT&G not launched a separate vape brand, despite having its current range of heated tobacco products such as Lil, Fiit, and MIX series?

 

As early as 2019, the South Korean Ministry of Health and Welfare recommended that the public stop using vapes and promised to quickly determine whether to ban the sale of e-cigarettes.

 

In October 2022, the Ministry of Health and Welfare in South Korea issued a strong recommendation regarding vape use, advising people to stop using the product until results from relevant harmfulness tests are released. Additionally, the South Korean government proposed a series of improvement measures to eliminate the regulatory "dead zone" for e-cigarettes.

 

The Korean Electronic Cigarette Association has stated that the government's recommendation only covers atomized products in electronic cigarettes. Following the government's strong suggestion, sales of Korean vapes plummeted by 70%.

 

The South Korean government's plan to ban e-cigarettes may have an impact on local company KT&G's e-cigarette sales. KT&G issued a statement claiming that their products do not contain harmful substances and that they will cooperate with the government's investigation.

 

Due to policy factors, KT&G has not devoted much research and development to vaporized electronic cigarettes. However, KT&G does possess vaporization technology, but according to its current product strategy focus on heat-not-burn products, it has combined the vaporization technology with non-combustion heating technology, applying both to its HNB brand products.

 

Using KT&G's Lil series products as an example, there are three main characteristics of the products: firstly, the combination of atomization and non-combustion heating technologies heats the pod up to 160 degrees, improving the taste and increasing smoke volume; secondly, the heating chamber of the pod is circular and does not come into contact with the tobacco, making it easy to clean; thirdly, the dual-core heating technology expands the heating area of the tobacco, resulting in more uniform heating.

 

The Lil series product booth of KT&G. Image source: Tobacco Online.

 

On December 12th, KT&G announced that they will expand the sales points of their new product from the Lil series, "lil AIBLE", to 20,000 locations. This includes an addition of 11,095 convenience stores in major cities such as Seoul, Busan, Incheon, Daegu, Gwangju, Sejong, Suwon, and Seongnam.

 

This shows that KT&G places a high importance on HNB products.

 

Table 1: Some Product Brands of KT&G and the Four Major Tobacco Companies.

 

Image source: Created by 2FIRSTS.

 

Products and technology of the big four tobacco companies.

 

The IQOS series of Heat-Not-Burn (HNB) products from Philip Morris International are primarily characterized by their central heating process, which heats tobacco to 350 degrees without combustion. This results in the release of a vapor containing salts and alkanes which reduces harmful substances. The IQOS Mesh line of vaporization products is characterized by the production of smoke from heating water vapor without tar, using a pod with a mesh design.

 

The unique features of the GIO series HNB products by British American Tobacco are as follows: First, heating is done in stages controlled by intelligent electronic devices to ensure the best flavor. Second, the heating method is a four-way radiating pattern from the center. Third, the pods are thinner and longer, resulting in faster heating. Fourth, the inhalable aerosol contains nicotine and has about 90-95% lower toxicity compared to conventional cigarettes. Finally, a special method of decomposing the tobacco into particle form within the pod resolves the issue of nicotine concentration limits by heating the tobacco at 240℃.

 

The Vuse series of atomization products from British American Tobacco uses the FEELM ceramic core developed by Smoore International, combining a metal film with a ceramic conductor to significantly improve flavor, consistency, and transmission efficiency. Vuse e-cigarettes received their PMTA last year, becoming the first FDA-authorized brand.

 

Japanese Tobacco has launched two types of pods for its Ploom S series of HNB products: regular and menthol. The selection of flavors is limited. The product uses ring heating technology, which is known for its low efficiency in heat utilization. The low temperature heating of the device results in a less intense flavor for the regular type, while the menthol type provides a cool sensation with its refreshing formula.

 

Eight products from the Logic line of vapor products under Japan Tobacco have received authorization from the United States Food and Drug Administration's Pre-Market Tobacco Application (PMTA) process. The Logicvape products include cotton products such as Logicpower and pro, as well as Logic Vapeleaf, which is a heat-not-burn (HNB) product similar to Ploom tech. The main difference is that it heats tobacco capsules with vapor at a lower temperature.

 

Imperial Tobacco's Pulze series HNB (heat-not-burn) products utilize an "inside-out" heating technology with two modes: 345-degree high temperature and 315-degree low temperature. The Blu series atomized products use nicotine salt technology, which increases nicotine concentration in the bloodstream compared to regular e-cigarettes and also allows for faster absorption.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04